← Back to Analyst Consensus 
NEUP Hold
Neuphoria Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 6
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 15, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Dec 5, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Sep 11, 2025 | Maxim Group | maintain | Buy → Buy | $35 | 41% |
| Aug 26, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Feb 4, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $21 | 44% |
Price Target Trend
Apr 24, 2026 Latest: $7 May 14, 2026
EPS Estimates
0y —
+1q —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days